Medical network - January 10, on January 9, social watches in the public medical institutions carrying out "two votes" drug purchase implementation opinions (try out) "officially announced.
It is reported, two votes will impact of small and medium-sized business, good business. Public data shows that at present our country a total of more than 13000 drug wholesale business licenses of circulation enterprises, annual sales of more than 50 million yuan less than 5% of the enterprise, concentration of wide disparity compared with developed countries.
And the same, on January 9, the state council issued by the "" much starker choices-and graver consequences-in" deepening the reform of medical health system planning (hereinafter referred to as "the reform plan"), which referred to "strive for to 2020, establish the ex-factory price of basic information traceability system, forming one mega pharmaceutical circulation enterprises with annual sales of more than 500 billion yuan, pharmaceutical wholesale enterprises annual sales accounted for more than 90% of the total amount of the wholesale market."
Released at the end of 2016, the ministry of commerce website "national medicine circulation industry development plan (2016-2020)", is also proposed that "by 2020, forming a group network covering the whole country, large pharmaceutical circulation enterprises of high intensive and information technology degree. Pharmaceutical wholesale enterprises with annual sales accounted for more than 90% of the total pharmaceutical wholesale market; drug retail enterprises with annual sales accounted for over 40% of the total amount of medicine retail market; the rate of drug retail chain of more than 50%."
"The reform plan," proposed, through the following five, to deepen the reform of the medicine circulation system:
1. Increase the intensity of medicines and chemical reagents, consumable materials circulation industry structure adjustment, guide the supply capacity equilibrium configuration, speed up the construction of drug circulation the national unified open, competitive and orderly market and break local protectionism and form a new modern circulation system.
2. Promote the drug circulation enterprise merger and reorganization and integration of pharmaceutical trading enterprises, warehousing and transport resources, speed up the development of pharmaceutical logistics, encourage regional drug distribution of urban and rural integration.
3. Promote the circulation enterprises to smart medical service transformation, construction and improve the supply chain integration system and support circulation enterprises to carry out service supply chain upstream and downstream.
4. Application of circulation data, develop value-added service depth and breadth, guide the industry development. Encourage the development of green medicine logistics, the development of the third party logistics and cold chain logistics. Support medicines and chemical reagents, consumable retail enterprise in pluralism, differential operation.
Popularization and application of modern logistics management and technology, medical electrical specification, development, improve the modern traditional Chinese medicinal materials circulation network and tracing system, promote the adjustment of industry structure, enhance the transparency and efficiency of trade.
And according to the policy of "two votes" design, since the implementation of the "two votes" part of the enterprise in the past by a ticket business company to complete basic by breaking the cycle of capital cost, make a ticket for a long time of the company's survival space is compressed, ticket function collapse, plus since may this year in the nationwide implementation of the "camp" instead tax reform policy, a large number of live on scalping business company under the combination of policy, the original value loss, facing out, enterprise in circulation will therefore policy will reduce a lot.
And "two votes" file in the provisions of the state of drug circulation group enterprise with wholly owned subsidiaries (holding) or a wholly owned subsidiary (holding) transfers between drug is not seen as a vote, will definitely good group medicine circulation enterprises; With the policy execution at the same time, a large number of agent type medicine commercial companies, small and medium-sized pharmaceutical commercial companies certainly will need to transform or seek takeover, to further speed up to large pharmaceutical circulation enterprises group mergers and reorganization release opportunities, further improve the concentration of drug distribution.
Circulation of experts on the issue further, said of a series of domino effect will quickly produce:
Two votes "will break
Drug market circulation patterns
To some extent industry costs will increase
left
Type of agent business
left
Prefecture-level distribution business
Opportunities for development
Can straight for the terminal
left
Large pharmaceutical business
Will quickly preempted market layout prefecture-level branch
Reserve agency industrial enterprises face challenges
With high open back or proprietary network enterprise facing opportunities
Those who live on scalping business company
Because you have lost the original value will be eliminated |
